Die neuen Virusvarianten sind nicht "milder" geworden, vielmehr besteht bei den meisten Personen mittlerweile Immunität durch Impfungen oder bereits überlebte Infektionen.
Weiterführende Links zum Artikel
★Antivirale Therapie in der Frühphase einer SARS-CoV-2-Infektion bei Patienten mit Risikofaktoren für einen schweren Verlauf von COVID-19 (bei asymptomatischen Patienten oder Patienten mit milder COVID-19)
(Hinzugefügt: 25.10.2022 um 13:53 Uhr)
Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe
(Hinzugefügt: 27.10.2024 um 15:27 Uhr)
Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021
(Hinzugefügt: 10.01.2022 um 11:44 Uhr)
Use of heat-not-burn tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2 vaccination among Japanese healthcare workers
(Hinzugefügt: 01.12.2021 um 18:01 Uhr)
Negative Association Between Smoking and Positive SARS-CoV-2 Testing: Results From a Swiss Outpatient Sample Population
(Hinzugefügt: 22.11.2021 um 08:50 Uhr)
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
(Hinzugefügt: 28.08.2021 um 13:39 Uhr)
Postoperative In-Hospital Morbidity and Mortality of Patients With COVID-19 Infection Compared With Patients Without COVID-19 Infection
(Hinzugefügt: 15.04.2021 um 05:59 Uhr)
Association Between Risk Factors for Complications From COVID-19, Perceived Chances of Infection and Complications, and Protective Behavior in the US
(Hinzugefügt: 01.04.2021 um 19:08 Uhr)
ystematic review of COVID-19 autopsies: accelerated hyaluronan concentration as the primary driver of morbidity and mortality in high-risk COVID-19 patients: with therapeutic introduction of an oral hyaluronan inhibitor in the prevention of "Induced Hyalur
(Hinzugefügt: 29.03.2021 um 18:31 Uhr)
SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via Toll-like receptor 4 signaling in murine and human macrophages
(Hinzugefügt: 02.02.2021 um 20:28 Uhr)
Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection
(Hinzugefügt: 02.12.2020 um 22:09 Uhr)